GlaxoSmithKline (Egypt) engages in the pharmaceutical and healthcare business. Its business operations are carried out through the production, packaging, marketing, sale, and distribution of medicines and other pharmaceutical products. The company was founded on January 14, 1981 and is headquartered in Cairo, Egypt.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company